Treatment of psoriatic arthritis with granulocyte and monocyte adsorption apheresis - 24/08/11
Abstract |
Granulocyte and monocyte adsorption apheresis (GCAP) is a new extracorporeal apheresis treatment modality that removes pathogenic granulocytes. Recently, we found that GCAP is useful for treating pyoderma gangrenosum and pustular psoriasis. We thought that this treatment may also be effective for treating other disorders attributable to activated granulocytes and studied the efficacy of GCAP in 4 patients with psoriatic arthritis. Treatment with GCAP resulted in remarkable clearing of joint pain, suggesting that GCAP is valuable for treating arthritis as well as skin disorders. We present a detailed description of these patients and this novel therapy.
Le texte complet de cet article est disponible en PDF.Plan
The GCAP columns used in this study were provided by Japan Immunoresearch Laboratories, Takasaki, Japan. Conflict of interest: None identified. |
Vol 50 - N° 2
P. 242-246 - février 2004 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?